Navigating Medical Ethics and Evidence

This chapter explores the critical differences between evidence-based and science-based medicine, with a focus on the implications of pharmaceutical industry practices. It emphasizes the need for transparency in clinical trials and government spending, highlighting the ethical responsibilities of researchers to safeguard patient trust. The discussion critiques the inadequacy of penalties for pharmaceutical misconduct and the urgent need for comprehensive clinical trial registries to enhance accountability.